| Die meistzitierten Artikel | Die meistzitierten Reviews | Die meistzitierten Köpfe |
Bild der meistzitierten Köpfe |
||
Die meistzitierten Artikel |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Czeh B, ..., Bartolomucci A, Fuchs E | Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine PNAS 98 (22): 12796-12801 OCT 23 2001 | 220 |
| 2. | Marsicano G, Wotjak CT, ..., Rammes G, ..., Hermann H, ..., Lutz B | The endogenous cannabinoid system controls extinction of aversive memories NATURE 418 (6897): 530-534 AUG 1 2002 | 219 |
| 3. | Sora I, ..., Lesch KP, ..., Uhl GR | Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference PNAS 98 (9): 5300-5305 APR 24 2001 | 129 |
| 4. | Crestani F, ..., Möhler H, Rudolph U | Trace fear conditioning involves hippocampal alpha(5) GABA(A) receptors PNAS 99 (13): 8980-8985 JUN 25 2002 | 114 |
| 5. | Tatarczynska E, ..., Gasparini F, ..., Pilc A | Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist BRITISH JOURNAL OF PHARMACOLOGY 132 (7): 1423-1430 APR 2001 | 107 |
| 6. | Jurd R, Arras M, Lambert S, Drexler B, Siegwart R, Crestani F, Zaugg M, Vogt KE, Ledermann B, Antkowiak B, Rudolph U. | General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta 3 subunit FASEB JOURNAL 16 (14): 250+ DEC 2002 | 106 |
| 7. | Bennett AJ, Lesch KP, ..., Higley JD | Early experience and serotonin transporter gene variation interact to influence primate CNS function MOLECULAR PSYCHIATRY 7 (1): 118-122 2002 | 95 |
| 8. | Keck ME, Welt T, Wigger A, Renner U, Engelmann M, ..., Landgraf R | The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats EUROPEAN JOURNAL OF NEUROSCIENCE 13 (2): 373-380 JAN 2001 | 84 |
| 9. | Conti AC, Cryan JF, ..., Blendy JA | cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs JOURNAL OF NEUROSCIENCE 22 (8): 3262-3268 APR 15 2002 | 83 |
| 10. | Abarca C, Albrecht U, Spanagel R | Cocaine sensitization and reward are under the influence of circadian genes and rhythm PNAS 99 (13): 9026-9030 JUN 25 2002 | 65 |
| 11. | Wang L, ..., Zimmer A, Kunos G | Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice PNAS 100 (3): 1393-1398 FEB 4 2003 | 65 |
Die meistzitierten Reviews |
|||
| Rang | Autoren | Paper | Zitierungen |
| 1. | Cryan JF, Markou A, Lucki I | Assessing antidepressant activity in rodents: recent developments and future needs TRENDS IN PHARMACOLOGICAL SCIENCES 23 (5): 238-245 MAY 2002 | 194 |
| 2. | Rudolph U, Crestani F, Möhler H | GABA(A) receptor subtypes: dissecting their pharmacological functions TRENDS IN PHARMACOLOGICAL SCIENCES 22 (4): 188-194 APR 2001 | 161 |
| 3. | Möhler H, Fritschy JM, Rudolph U | A new benzodiazepine pharmacology JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 300 (1): 2-8 JAN 2002 | 142 |
| 4. | Bannerman DM, ..., Yee BK, Bast T, Zhang WN, ..., Feldon J | Regional dissociations within the hippocampus - memory and anxiety NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 28 (3): 273-283 MAY 2004 | 70 |
Die meistzitierten Köpfe |
||||
| Rang | Name | Ort | Zitierungen | Artikel |
| 1 | Klaus-Peter Lesch | Psychiatrie, Uni Würzburg | 1271 | 64 |
| 2 | Joram Feldon | Verh.neurobiol, ETH Zürich | 1074 | 80 |
| 3 | Beat Lutz | Physiol Chem, Uni Mainz (bis 2005 München) | 948 | 22 |
| 4 | Andreas Zimmer | Mol Psychiatrie, Uni Bonn | 922 | 22 |
| 5 | Giovanni Marsicano | Mol Neurogen, MPI Psych München | 876 | 16 |
| 6 | Wolfgang Froestl | TA Nervensystem, Novartis Basel | 776 | 28 |
| 7 | Eberhard Fuchs | Neurobiol, Deutsches Primatenzentrum DPZ Göttingen | 714 | 33 |
| 8 | Rainer Landgraf | Verh.neuroendokrinol, MPI Psych München | 710 | 35 |
| 9 | David Paul Wolfer | Neuroanat & Verh, Uni Zürich | 672 | 29 |
| 10 | Hans-Peter Lipp | Neuroanat & Verh, Uni Zürich | 668 | 36 |
| 11 | Klemens Kaupmann | TA Nervensystem, Novartis Basel | 612 | 15 |
| 12 | Heike Hermann | Mol.gen Verh, MPI Psych München | 599 | 10 |
| 13 | Marianne B. Müller | Mol Stressphysiol, MPI Psych München | 575 | 18 |
| 14 | Fabrizio Gasparini | TA Nervensystem, Novartis Basel | 561 | 16 |
| 15 | Gerhard Rammes | Klin Neuropharmakol, MPI Psych München | 549 | 23 |
| 16 | Uwe Rudolph | Pharmakol & Toxikol, Uni Zürich | 541 | 23 |
| 17 | Boldizsár Czéh | Neurobiol, Deutsches Primatenzentrum Göttingen | 517 | 14 |
| 18 | Joachim Spiess | Mol Neuroendokrinol, MPI Exp Med Göttingen | 512 | 30 |
| 19 | Alexandra Wigger | Verh.neuroendokrinol, MPI Psych München | 490 | 15 |
| 20 | Carsten T. Wotjak | Mol Neurogen, MPI Psych München | 486 | 18 |
| 21 | Martin E. Keck | Neuroendokrinol, MPI Psych München | 477 | 18 |
| 22 | Onur Güntürkün | Biopsychologie, Uni Bochum | 448 | 35 |
| 23 | Rainer Spanagel | Psychopharmakol, ZI Mannheim (bis 2005 München) | 443 | 24 |
| 24 | Rainald Mößner | Psychiatrie, Uni Würzburg | 436 | 28 |
| 25 | John F. Cryan | (seit 2005 Irland) Verh.pharmakol, Novartis Basel | 421 | 14 |
| Joseph P. Huston | Physiol Psychol, Uni Düsseldorf | 421 | 50 | |
| 27 | Peter Gass | Verh.biol, ZI Seelische Gesundheit Mannheim | 415 | 23 |
| 28 | Gilles Sansig | TA Nervensystem, Novartis Basel | 411 | 8 |
| 29 | Hanns Möhler | Pharmakol & Toxikol, Uni Zürich | 379 | 18 |
| 30 | Nicola Toschi | Verh.neuroendokrinol, MPI Psych München | 376 | 10 |
| 31 | Guy A. Higgins | Vorklin ZNS-Forschung, Hoffmann-La Roche Basel | 371 | 23 |
| 32 | Alessandro Bartolomucci | Neurobiol, DPZ Göttingen | 370 | 14 |
| 33 | Will P. J. M. Spooren | TA Nervensystem, Novartis Basel | 349 | 9 |
| 34 | Tobias Welt | Neuroendokrinol, MPI Psych München | 347 | 9 |
| 35 | Inga Neumann | Verh.neuroendokr, Uni Regensburg (bis 2001 München) | 346 | 15 |
| 36 | Christian A. Heidbreder | Verh.neurobiol, ETH Zürich | 345 | 31 |
| 37 | Randolf Menzel | Neurobiol, FU Berlin | 330 | 23 |
| 38 | Mario Engelmann | Med Neurobiol, Uni Magdeburg | 324 | 28 |
| 39 | Inge Sillaber | (seit 2005 Affectis, München) MPI Psych München | 315 | 11 |
| 40 | Florence Crestani | Pharmakol & Toxikol, Uni Zürich und ETH | 306 | 6 |
| 41 | Krisztina Monory | Physiol Chem, Uni Mainz (bis 2005 München) | 299 | 9 |
| 42 | Nicolas Singewald | Pharmakol & Toxicol, Uni Innsbruck | 297 | 23 |
| 43 | Christopher R. Pryce | Verh.neurobiol, ETH Zürich | 293 | 20 |
| 44 | Peter H. Kelly | TA Nervensystem, Novartis Basel | 292 | 7 |
| 45 | Heidrun Fink | Pharmakol & Toxicol, Vet Med FU Berlin | 284 | 23 |
| 46 | Axel Becker | Pharmakol & Toxicol, Uni Magdeburg | 281 | 31 |
| 47 | Frauke Ohl | (seit 2005 Utrecht) Verh.phänotyp, MPI Psych München | 267 | 13 |
| 48 | Tobias Bast | (seit 2004 Edinburgh) Verh.neurobiol, ETH Zürich | 254 | 18 |
| 49 | Hans Welzl | Anat & Zentr Neurowissenschaften, Uni Zürich | 251 | 10 |
| 50 | Kaspar Vogt | Institute of Pharmacology, University of Zurich | 249 | 4 |
| 51 | Jelena Radulovic | MPI Exp Med Göttingen | 244 | 15 |
| 52 | Martin Heisenberg | Gen & Neurobiol, Biozentrum Uni Würzburg | 241 | 18 |
